Companies: 10,795·Total market cap: $144.5T
Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

FULCNASDAQHealthcare● Active
$3.51
$-0.18(-4.88%)
Market Cap$189930937
P/E Ratio
52W High$15.74
52W Low$2.83
Overview

Fulcrum Therapeutics, Inc.(FULC)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · FULC · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.08B$0.00B$0.01B$0.02B
Cost of Revenue$0.00B$0.06B$0.00B$0.08B$0.07B
Gross Profit($0.00B)$0.02B$0.00B($0.07B)($0.05B)
Gross Margin %(computed)20.77%100.00%-263.73%
Operating Expenses
R&D Expenses$0.06B$0.06B$0.07B$0.08B$0.07B
G&A Expenses$0.03B$0.03B$0.04B$0.04B$0.03B
Total Operating Expenses$0.08B$0.04B$0.11B$0.04B$0.03B
Operating Income($0.08B)($0.02B)($0.11B)($0.11B)($0.08B)
Operating Margin %(computed)-27.37%-422.97%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.07B)($0.01B)($0.10B)($0.11B)($0.08B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.07B)($0.01B)($0.10B)($0.11B)($0.08B)
Net Margin %(computed)-12.16%-421.89%
Per Share & EBITDA
EPS (Basic)$-1.18$-0.16$-1.59$-2.35$-2.22
Wtd Avg Shares0.06B0.06B0.06B0.04B0.04B
EBITDA($0.07B)($0.02B)($0.11B)($0.11B)($0.08B)
EBITDA Margin %(computed)-22.80%-409.85%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Fulcrum Therapeutics, Inc.

关于Fulcrum Therapeutics, Inc.(FULC)损益表

Fulcrum Therapeutics, Inc.(FULC)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,FULC实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.07B)(净利率—)。

常见问题

FULC · 4 问

Fulcrum Therapeutics, Inc.(FULC)2025财年营收为$0.00B,同比down100.0%。

FULC revenueFULC salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08